RecruitingNCT05847634

Depth of Sedation and Its Impact on Cerebrovascular Reactivity in Acute Respiratory Distress Syndrome: a Pilot Analysis


Sponsor

University of Manitoba

Enrollment

40 participants

Start Date

Nov 25, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Investigation of the feasibility of monitoring processed transcutaneous electroencephalography (EEG), a method of interpreting brain activity, and near-infrared spectroscopy (NIRS), a method of determining levels of tissue oxygenation (StO2) in the brain, for patients with acute respiratory distress syndrome (ARDS) in the ICU.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Adult patient admitted to the ICU
  • ARDS confirmed according to the Berlin Definition
  • Invasive mechanical ventilation
  • Deep sedation and/or neuromuscular blockade required for ARDS treatment at the discretion of the treating medical team
  • Application of monitoring devices feasible

Exclusion Criteria5

  • More than 24 hours elapsed since ICU admission
  • Death is deemed imminent and inevitable during the next 24 hours
  • Known allergy to a textile component of the device
  • Consent declined from patient or authorized third party
  • The treating clinician believes that participation in the study would not be in the best interest of the patient

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMasimo O3 NIRS cerebral oximetry and SedLine processed EEG

Non-invasive neuromonitoring device for observational study


Locations(1)

Health Sciences Centre Winnipeg

Winnipeg, Manitoba, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05847634


Related Trials